Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01. December 2021
Solactive China Healthcare Disruption Index:
In the ordinary rebalancing effective open December 01, 2021 the following index composition was implemented:
3SBIO INC | 0.817 % |
AKESO INC | 1.968 % |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 4.7099 % |
ALPHAMAB ONCOLOGY | 0.8634 % |
ANGELALIGN TECHNOLOGY INC | 2.8904 % |
BEIGENE LTD | 7.616 % |
BRII BIOSCIENCES LTD | 1.565 % |
CANSINO BIOLOGICS INC | 3.8136 % |
CARSGEN THERAPEUTICS HOLDING | 1.0965 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 1.5364 % |
CLOVER BIOPHARMACEUTICALS LT | 0.6749 % |
GENSCRIPT BIOTECH CORP | 4.1816 % |
HANSOH PHARMACEUTICAL GROUP CO | 4.5784 % |
INNOCARE PHARMA LTD | 1.4478 % |
INNOVENT BIOLOGICS INC | 4.9171 % |
JD HEALTH INTERNATIONAL INC | 7.741 % |
JOINN LABORATORIES CHINA C-H | 2.9259 % |
KINTOR PHARMACEUTICAL LTD | 1.0606 % |
LIFETECH SCIENTIFIC CORP | 0.9511 % |
MICROPORT CARDIOFLOW MEDTECH | 0.5485 % |
MICROPORT SCIENTIFIC CORP | 2.8818 % |
NEW HORIZON HEALTH LTD | 0.6152 % |
PEIJIA MEDICAL LTD | 0.5453 % |
PING AN HEALTHCARE AND TECHNOL | 1.638 % |
REMEGEN CO LTD-H | 2.5166 % |
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 2.4201 % |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 2.7337 % |
SHANGHAI MICROPORT MEDBOT GR | 2.793 % |
SIMCERE PHARMACEUTICAL GROUP | 1.187 % |
SINO BIOPHARMACEUTICAL LTD ORD | 5.2055 % |
VENUS MEDTECH HANGZHOU INC | 0.8463 % |
WUXI APPTEC CO LTD | 8.9125 % |
WUXI BIOLOGICS CAYMAN INC | 8.1786 % |
YIDU TECH INC | 1.0196 % |
ZAI LAB LTD | 2.6038 % |